Functional genomics approaches to improve pre‐clinical drug screening and biomarker discovery
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Functional genomics approaches to improve pre‐clinical drug screening and biomarker discovery ; day:13 ; month:07 ; year:2021 ; extent:14
EMBO molecular medicine / European Molecular Biology Organization ; (13.07.2021) (gesamt 14)
- Urheber
-
Nguyen, Long V.
Caldas, Carlos
- DOI
-
10.15252/emmm.202013189
- URN
-
urn:nbn:de:101:1-2021071315043229013078
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nguyen, Long V.
- Caldas, Carlos
Ähnliche Objekte (12)
Biomarker discovery
atBioNet– an integrated network analysis tool for genomics and biomarker discovery
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets
Text mining for genomics based drug discovery
Metagenomic biomarker discovery and explanation
Biomarker discovery an related topics, 2
Opportunities for pharmacoproteomics in biomarker discovery
Avoiding false discovery in biomarker research
Revisiting biomarker discovery by plasma proteomics
Advanced technologies, including new biomarker discovery
Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical models
Genomics-driven drug discovery based on disease-susceptibility genes
Biomarker discovery
atBioNet– an integrated network analysis tool for genomics and biomarker discovery
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets
Text mining for genomics based drug discovery
Metagenomic biomarker discovery and explanation
Biomarker discovery an related topics, 2
Opportunities for pharmacoproteomics in biomarker discovery
Avoiding false discovery in biomarker research
Revisiting biomarker discovery by plasma proteomics
Advanced technologies, including new biomarker discovery
Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical models
Genomics-driven drug discovery based on disease-susceptibility genes
Biomarker discovery
atBioNet– an integrated network analysis tool for genomics and biomarker discovery
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets
Text mining for genomics based drug discovery
Metagenomic biomarker discovery and explanation
Biomarker discovery an related topics, 2
Opportunities for pharmacoproteomics in biomarker discovery
Avoiding false discovery in biomarker research
Revisiting biomarker discovery by plasma proteomics
Advanced technologies, including new biomarker discovery
Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical models